Search⌘K

LLEli Lilly

9 Nov 2026
WhatsAppTelegramXLinkedIn
All entries for this assetTo the dayTo the live pageTo PulseDaily feedLive feed

Entry

LLY · Health care
+2.93%×2.5 usualOwn move

Coincided with

  • Lilly's weight-loss pill meets main goal in late-stage sleep apnea study
  • Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval
Next day+1.44%continued5 days+1.40%continued

Same day

Other moves of this asset